We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: FINDER is the first molecular point-of-care platform with both FDA 510(k) clearance and CLIA waiver that combines molecular testing with chemistry, coagulation, and immunoassay capabilities on a single multifunctional system (photo courtesy of Baebies)

Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

Baebies has received FDA 510(k) clearance and CLIA waiver for the FINDER Flu A&B/SARS-CoV-2 Test. More...
07 Apr 2026
Image: Monitoring ctDNA is a powerful tool to assess the absence or presence of MRD (Photo courtesy of Natera)

ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery

A circulating tumor DNA-based molecular residual disease test identifies older ER+/HER2- breast cancer patients who may forgo surgery. More...
06 Apr 2026
Image: Caris Detect uses AI models to analyze peripheral blood for subtle signals of early-stage cancer (photo credit: Adobe Stock)

WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity

A new WGS-based multi-cancer blood test shows stage-stratified sensitivity with high specificity. More...
06 Apr 2026
image: HPV DNA (ctDNA) measured in blood could help tailor treatment for HPV-related throat cancer (photo credit: Adobe Stock)

Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer

New data show circulating tumor HPV DNA, read with pathology, improves risk stratification to tailor therapy in throat cancer. More...
03 Apr 2026
Image: New findings show that transcriptome-enabled profiling can help identify therapeutic opportunities for patients who previously had no actionable results from DNA-only testing (photo courtesy of Shutterstock)

RNA Profiling Uncovers Therapeutic Targets in Solid Tumors

AI-driven RNA profiling reveals therapeutic targets missed by DNA testing in advanced solid tumors. More...
02 Apr 2026
Image: Workflow of ProtAIDe-Dx on GNPC (An, L., Pichet Binette, A., Hristovska, I. et al. Nature Medicine (2026). https://doi.org/10.1038/s41591-026-04303-y)

AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample

An AI approach analyzes proteins in a single blood sample to detect several brain diseases simultaneously.  More...
02 Apr 2026
Image: The integration of clinical medicine and advanced genomics supports a shift toward more precise, personalized care (photo courtesy of Shutterstock)

Whole Genome Sequencing in Routine Care Expands Rare Disease Detection

New data supports the integration of whole genome sequencing (WGS) into routine diagnostic investigations for rare diseases. More...
01 Apr 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Platelet Function Analyzer
PL-12


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.